한글목차

세계 POC(Point-of-Care) 진단 시장 규모는 2023년 369억 달러, 2024년 406억 달러에서 예측 기간 동안 연평균 10.2% 성장하여 2029년 말에는 659억 달러에 달할 것으로 예상됩니다.

북미 시장은 2024년 168억 달러에서 2029년 말까지 10.5%의 연평균 성장률(CAGR)을 기록하며 277억 달러로 성장할 것으로 예상됩니다. 아시아태평양은 2024년 91억 달러에서 2029년 말까지 11.2%의 CAGR로 154억 달러로 성장할 것으로 예상됩니다.

세계의 POC(Point-of-Care) 진단 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 개요
• POC를 위한 새로운 접근법
• 미국에서 CLIA의 중요성
• 규제 가이드라인
• 적정 제조 규범
• POC 시험에서 FDA의 역할
• 결론

제3장 시장 역학

• POC(Point-of-Care) 진단 시장에 영향을 미치는 요인
• 시장 성장 촉진요인
• 감염증의 높은 발생률
• 만성질환 증가
• 자가 검사 수요 증가
• 고령화 사회
• 시장 성장 억제요인
• 가격 압력에 의해 POC 제조업체가 직면하는 과제
• 기술적인 복잡성
• 전문적인 훈련의 결여
• 시장 과제
• 원격지에서 POC(Point-of-Care) 진단의 도입 과제
• POC(Point-of-Care) 진단의 환경과 오염 과제
• 시장 기회
• R&D 예산 증가
• AI와 ML의 통합에 의한 POCT의 우수한 시장 가능성
• 신흥 경제국

제4장 시장 세분화 분석

• 세분화 내역
• POC(Point-of-Care) 진단 시장 : 검사 유형별
• 약물 및 알코올 검사
• 혈액가스 전해질 및 대사물(BGEM)
• 심장 마커
• 콜레스테롤 검사/모니터링
• 혈당치 검사·모니터링
• 감염증 검사
• 임신·생식 능력 검사
• 헤모글로빈·지혈
• 종양 마커
• 소변 검사/소변 화학
• 기타
• POC(Point-of-Care) 진단 시장 : 제품별
• 하드웨어
• 소프트웨어
• POC(Point-of-Care) 진단 시장 : 최종사용자별
• 병원·집중치료실
• 홈케어 설정
• 지역적 내역
• POC(Point-of-Care) 진단 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 시장의 신기술과 향후 기술

• 신기술과 향후 기술
• POC(Point-of-Care) 진단의 AI
• CRISPR-Cas 시스템
• 3D 래피드 프로토타이핑
• 양자점
• RFID와 NFC
• 스마트폰 기반 의료 영상
• 병원체 검출용 POC 디바이스의 나노재료
• 미세유체 기반 센싱 기술
• 클라우드 통합 AI
• D3 어레이-UTI
• EVIK DxSpheres : 견고한 어세이 솔루션
• UNIQO 160 자동 IIFT 시스템

제6장 ESG 전개

• 플라스틱과 바이오 기반 대체품의 지속가능성
• ESG 리스크 평가
• WHO Global Action Plan
• BCC에 의한 견해

제7장 경쟁 상황

• M&A·제휴
• 전략적 제휴
• FDA 승인
• 특허 분석
• 특허 분석 : 연도별
• 기업 점유율 분석

제8장 부록

• 조사 방법
• 정보 출처
• 약어
• 기업 개요
• ABBOTT
• BD
• DANAHER CORP.
• GE HEALTHCARE
• F. HOFFMANN-LA ROCHE LTD.
• MEDTRONIC
• QUEST DIAGNOSTICS INC.
• QUIDELORTHO CORP.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

The North American market for point-of-care diagnostics is expected to grow from $16.8 billion in 2024 to $27.7 billion by the end of 2029, at a CAGR of 10.5% from 2024 through 2029.

The Asia-Pacific market for point-of-care diagnostics is expected to grow from $9.1 billion in 2024 to $15.4 billion by the end of 2029, at a CAGR of 11.2% from 2024 through 2029.

Report Scope

The point-of-care diagnostics market is extensive and constantly evolving with new technologies and methodologies. This report explores the current and future market potential, competitive environment, regulatory scenario, and market trends, including projections through 2029 and an analysis of key players.

This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, and urine chemistry, and it includes comprehensive regional analyses.

The report highlights ongoing R&D efforts focused on improving accuracy accessibility and incorporating innovative diagnostic procedures. It provides insights into market drivers, challenges, opportunities, industry status, developments, trends, and strategies like mergers, acquisitions, and collaborations. It is a valuable resource for market players, potential entrants, government agencies, and other stakeholders, especially those interested in geographic expansion.

Report Includes

• 98 data tables and 46 additional tables
• An overview of the global markets and technologies for point-of-care (POC) diagnostics
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the PoC diagnostics market, with market share analysis by test type, product type, end user, and region
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Coverage of government regulations and policies, R&D initiatives, exploration activities, and government programs
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Abbott, BD, Danaher Corp., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Novel Approaches for POC
• Significance of CLIA in the United States
• Regulatory Guidelines
• Good Manufacturing Practice
• The FDA's Role in POC Testing
• Conclusion

Chapter 3 Market Dynamics

• Factors Affecting the Point-of-Care Diagnostic Market
• Market Drivers
• High Incidences of Infectious Diseases
• Growing Prevalence of Chronic Diseases
• Increasing Demand for Self-Testing
• Aging Population
• Market Restraints
• Challenges Faced by POC Manufacturers Due to Pricing Pressure
• Technical Complexity
• Lack of Specialized Training
• Market Challenges
• Challenges in Deploying Point-of-Care (POC) Diagnostics in Remote Settings
• Environmental and Contamination Challenges in Point-of-Care Diagnostics
• Market Opportunities
• Increasing R&D Budget
• Excellent Market Potential for POCT with AI and ML Integration
• Emerging Economies

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Point-of-Care Diagnostics Market, by Test Type
• Drug and Alcohol Screening
• Blood Gas Electrolyte and Metabolite (BGEM)
• Cardiac Markers
• Cholesterol Testing/Monitoring
• Glucose Testing and Monitoring
• Infectious Disease Testing
• Pregnancy and Fertility Testing
• Hemoglobin and Hemostasis
• Tumor Marker
• Urinalysis/Urine Chemistry
• Others
• Point-of-Care Diagnostics Market, by Product
• Hardware
• Software
• Point-of-Care Diagnostics Market, by End User
• Hospitals and Critical Care Settings
• Home Care Settings
• Geographic Breakdown
• Point-of-Care Diagnostics Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 5 Emerging and Upcoming Technologies in the Market

• Emerging and Upcoming Technologies
• AI in Point-of-Care Diagnostics
• CRISPR-Cas Systems
• 3D Rapid Prototyping
• Quantum Dots
• RFID (Radio-Frequency Identification) and NFC (Near Field Communication)
• Smartphone-Based Medical Imaging
• Nanomaterials in POC Devices for Pathogen Detection
• Microfluidics-Based Sensing Technologies
• Cloud-Integrated AI
• D3 Array-UTI
• EVIK DxSpheres: A Solid Assay Solution
• UNIQO 160 Automated IIFT System
• Recent Developments

Chapter 6 ESG Development

• Introduction
• Sustainability in Plastics and Bio-Based Alternatives
• ESG Risk Ratings
• The WHO Global Action Plan
• BCC Research Viewpoint

Chapter 7 Competitive Landscape

• Mergers, Acquisitions and Collaborations
• Strategic Alliances
• FDA Approvals
• Patent Analysis
• Patent Analysis, by Year
• Company Share Analysis

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• BD
• DANAHER CORP.
• GE HEALTHCARE
• F. HOFFMANN-LA ROCHE LTD.
• MEDTRONIC
• QUEST DIAGNOSTICS INC.
• QUIDELORTHO CORP.
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.